ANEB- Anebulo Pharmaceuticals, Inc.

Name: Anebulo Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Anebulo Pharmaceuticals, Inc. (ANEB) has 0 insiders with recent SEC Form 4 filings, including 5 buys and 0 sells. ANEB is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d

Activity

Buys and sells only

Transactions

5 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 23, 2024	English Aron R.	Director, 10% Owner	Buy	10,101,010	$0.99	$9,999,999.90	+188.2%	+26.4%	-4.8%
Dec 17, 2021	English Aron R.	Director, 10% Owner, See Explanation Of Responses	Buy	400	$6.59	$2,634.32	-	-9.1%	-64.2%
Dec 14, 2021	English Aron R.	Director, 10% Owner, See Explanation Of Responses	Buy	412	$5.90	$2,428.74	-	+20.1%	-54.3%
Dec 3, 2021	English Aron R.	Director, 10% Owner, See Explanation Of Responses	Buy	4,500	$5.93	$26,685.00	+0.1%	-0.3%	-61.1%
Dec 2, 2021	English Aron R.	Director, 10% Owner, See Explanation Response	Buy	13,836	$5.30	$73,330.80	+0.4%	+5.3%	-59.1%

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC